A Double-Blind, Randomized, Vehicle-Controlled Dose Ranging Study of the Effect of INCB018424 Phosphate Cream When Applied to Patients With Plaque Psoriasis.
Phase of Trial: Phase II
Latest Information Update: 25 Jul 2017
At a glance
- Drugs Ruxolitinib (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Incyte Corporation
- 12 May 2010 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 12 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Oct 2009 New trial record.